Three independent comparison studies out now praise the top-level performance of the Troponin (I) assay on Radiometer’s AQT90 FLEX immunoassay analyzer. According to them, the quality of the AQT90 FLEX’s analytical performance and its ease of use make the instrument ideal for the critical settings such as Emergency Departments (ED) and cardiac care units.

Top-level performance of TnI assay

All the three studies have found that the value of the Troponin I assay on the AQT90 FLEX with a 10 % coefficient of variation (CV) is very close to the 99th percentile, which fully complies with internationally recommended performance levels for that assay. Because of the instrument’s automated steps and ease of use, the studies go on to recommend the AQT90 FLEX for testing of cardiac markers at the point of care.

Performance evaluation of the new point-of-care testing for cardiac Troponin I with the Radiometer AQT90 FLEX analyzer – Italy

A preliminary evaluation of the AQT90 FLEX TnI immunoassay – Finland

A Correlation between the Radiometer AQT90 FLEX POC system and the Abbott i2000SR immunoassay system for Troponin I – Australia

Compelling solution for the point of care

In addition to Troponin I, the AQT90 FLEX also measures CKMB, Myoglobin, NT-proBNP, CRP, D-dimer and βhCG.  Troponin T is in the pipeline for later on this year. The comprehensive test panel makes the AQT90 FLEX a compelling solution for emergency rooms and intensive care units looking to improve the measurement of these assays at the point of care.

Learn more about AQT90 FLEX

About Radiometer

Radiometer is a world leader in the development, manufacturing and distribution of technologically advanced acute care testing solutions. Radiometer’s products and services simplify and automate all phases of acute care testing, so hospitals can get fast results, reduce their workload and the risk of errors, and improve cost effectiveness.